IRVINE, Calif.--(BUSINESS WIRE)--Dec. 29, 2015--
Masimo
(NASDAQ: MASI) today announced that its management is scheduled to
present at the 34th Annual J.P. Morgan Healthcare Conference at the
Westin St. Francis Hotel in San Francisco on Tuesday, January 12, 2016,
at 4:30 p.m. Pacific Time. A live audiocast of the presentation will be
available on the Masimo website at www.masimo.com.
A replay of the audiocast will be available following the live
presentation.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry,
which has been shown in multiple studies to significantly reduce false
alarms and accurately monitor for true alarms. The benefits of Masimo SET®
have been proven in more than 100 independent and objective
studies and it is estimated to be used on more than 100 million patients
in leading hospitals and other healthcare settings around the world. In
2005, Masimo introduced rainbow® Pulse CO-Oximetry
technology, allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®),
and more recently, Pleth Variability Index (PVI®) and Oxygen
Reserve Index (ORI™), in addition to SpO2, pulse rate, and
perfusion index (PI). In 2014, Masimo introduced Root®, an
intuitive open architecture patient monitoring and connectivity platform
designed to speed the pace of innovation and reduce the cost of care.
Masimo is also taking an active leadership role in mHealth with products
such as the Radius-7™ wearable patient monitor and the
MightySat™ fingertip pulse oximeter. Additional information
about Masimo and its products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care... by Taking Noninvasive Monitoring to New
Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are
trademarks or registered trademarks of Masimo Corporation
View source version on businesswire.com: http://www.businesswire.com/news/home/20151229005018/en/
Source: Masimo
Masimo
Investor Contact:
Eli Kammerman
(949)
297-7077
ekammerman@masimo.com
or
Media
Contact:
Irene Paigah
(858) 858-7001
irenep@masimo.com